Hepatitis Weekly articles from November 2001

Hepatitis Weekly archives from November 2001

Hepatitis B Interferon Nonresponders Improve Upon Sequential Dosing.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Patients infected with hepatitis B virus (HBV) who do not respond to interferon (IFN) monotherapy might improve if offered drug regimens that alternate IFN...

Hepatitis B Vaccine Response Falls Short In Youth, Those With HIV.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Older adolescents may not be fully protected after being vaccinated against hepatitis B virus. Furthermore, youth who are infected with human...

Epstein-Barr Virus Not A Factor In American Cases Of Primary Liver Cancer.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Although recent reports have shown a link between Epstein-Barr virus (EBV) and hepatocellular carcinoma (HCC), or primary liver cancer, in the Japanese, studies...

Protein Could Be Important Hepatitis B Therapy For Humans.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Animal model studies indicate granulocyte-macrophage colony stimulating factor (GM-CSF) could be an effective therapy for humans infected with hepatitis B virus...

Fibrosis Markers Reflect Liver Appearance After Hepatitis C Virus Therapy.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Interferon has been, for several years now, an important therapy for patients infected with hepatitis C virus (HCV). Unfortunately, interferon (IFN) is...

Group Studies Estrogen Receptors And Cancer Prevention In Chronic Hepatitis C.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Estrogen, a hormone rarely mentioned without inciting controversy, may prevent liver cancer in patients chronically infected with hepatitis C virus (HCV). ...

Immune-Regulating Hormone Enters Clinical Trials.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- Hollis-Eden Pharmaceuticals, Inc. announced that it has received approval to initiate a Phase II clinical trial in hepatitis B (HBV) infected patients with its investigational drug, HE2000, at Mt....

Acetaminophen Not Linked To Liver Injury In Alcoholics.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- Results of a recent study show repeated use of the maximum recommended daily dose of acetaminophen, the medicine in Tylenol, is not associated with evidence of liver (hepatic) injury - even in high-risk...

Study To Examine Race And Response To Hepatitis C Therapy.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- A national, multisite study coordinated by the University of Pittsburgh Graduate School of Public Health (GSPH), Pennsylvania, will, for the first time, examine differences in how blacks and whites...

Phase II Trial Initiated By Ribozyme Pharmaceuticals.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- Ribozyme Pharmaceuticals (RPI) announced the beginning of a multicenter Phase II clinical trial utilizing Heptazyme for the treatment of patients with chronic hepatitis C. Heptazyme, developed by...

Baculovirus Extends Study Of Gene Transfer In Hepatocytes.
November 5, 2001... 2001 NOV 5 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Scientists have found they can increase their ability to study baculovirus-induced gene transfection in liver cells by depleting extracellular calcium. ...

Diabetes, Liver Disease, and Viral Hepatitis Interrelated.
November 12, 2001... 2001 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Patients with virus-related hepatitis or liver cirrhosis are four times more likely to acquire diabetes mellitus, the authors of an Italian study report. ...

PMEA-LO: Lipoprotein Conjugate More Effective For Viral Inhibition.
November 12, 2001... 2001 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A research group has made a compound, currently under investigation, for treating chronic hepatitis B look more appealing by changing its delivery mechanism....

Metabolite Betaine Improves Liver Status In Nonalcoholic Steatohepatitis.
November 12, 2001... 2001 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Betaine, a byproduct of choline metabolism, improves liver function and pathology in patients with nonalcoholic steatohepatitis (NASH), or fatty liver. ...

Vaccine Program Suspected In Pakistani Hepatitis C Transmissions.
November 12, 2001... 2001 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Officials in Pakistan suspect the high prevalence of hepatitis C virus (HCV) cases in the adult population could be related to vaccines administered during an...

Bio-Terrorism.Info Database and Weekly Report Launch Powered by NewsRx Artificial Intelligence Technology.
November 12, 2001... 2001 NOV 12 - (NewsRx.com & NewsRx.net) -- NewsRx has leveraged its technology platform to create Bio-Terrorism.Info, a new database and weekly report. NewsRx is the leading provider of life science databases and daily and weekly health news....

Epstein-Barr Virus Based Vectors Target Liver Cells Better.
November 12, 2001... 2001 NOV 12 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - After finding some Epstein-Barr virus (EBV)-based plasmid vectors seem to target liver cells, researchers in Japan have proposed these vectors might be...

ICN Pharmaceuticals Acquires Hep B Compound.
November 12, 2001... 2001 NOV 12 - (NewsRx.com & NewsRx.net) -- ICN Pharmaceuticals Inc., a research-based global pharmaceutical company, has licensed a promising liver-targeting hepatitis B compound from Metabasis Therapeutics of San Diego, California. This...

Many New Blood Donors Will Learn They Are Infected.
November 12, 2001... 2001 NOV 12 - (NewsRx.com & NewsRx.net) -- The American Liver Foundation salutes the hundreds of thousands of Americans who graciously rolled up their sleeves to donate blood for the victims of the terrorist attacks on September 11, 2001. ...

Cytokine Levels Correlate With Liver Toxicity In Acetaminophen Overdose.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - U.S. scientists report levels of the proinflammatory cytokine interleukin (IL)-8 tend to rise along with liver enzyme levels in youngsters who overdose on...

Transformed Bacteria Produce HCV-Specific Immune Response In Mice.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - U.S. National Institutes of Health (NIH) researchers report they have transformed Salmonella bacteria so that it elicits an immune response against hepatitis C...

More Evidence Of Link Between Liver Disease And Diabetes Seen In Japan.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A growing body of evidence has begun to support a positive link between liver disease and diabetes. Previously, researchers in Italy reported virus-related...

Cirrhosis Progression In Chronic Hepatitis C Lower Than Reported.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - After conducting an exhaustive review of scientific literature, investigators in Australia say actual progression to cirrhosis in young adults with...

Soluble Fas Antigen Predicts Poor Response To Interferon In Hepatitis C.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Soluble Fas antigen may be related to response to interferon (IFN) in patients with chronic hepatitis C. "Fas system-mediated cytotoxicity is thought to be...

African-American Physicians Group Issues Hepatitis Guidelines.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- Calling for universal vaccination, increased education, advocacy efforts and ongoing surveillance and research to help eliminate hepatitis in the African-American community, The National Medical...

Cisplatin/Epinephrine Demonstrates Versatility In Controlling Solid Tumors.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- Study results contained in three presentations made by Matrix Pharmaceutical, Inc., at the European Congress on Clinical Oncology (ECCO) meeting in Lisbon, Portugal in late October 2001 helped...

Article Describes New "Golden Age" Of Antiviral Drugs And Vaccines.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- Advances in the study of viral genomes has laid the foundation for rapid progress in the development of new antiviral vaccines and drugs. "The 1950s were the golden age of antibiotics to treat...

Novelos And HealthCare Asia To Commercialize Agent In China.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- Novelos Therapeutics, Inc., has entered into a collaboration with HealthCare Asia Pharmaceuticals, Inc. (Hong Kong, China), whereby HealthCare Asia will develop and commercialize BAM-205 for hepatitis...

Treatment Strategy Doubles Efficacy In HIV Coinfected Patients.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- Daily administration of interferon alfa-2b in combination with ribavirin for the treatment of the hepatitis C virus (HCV) is more than twice as effective as the standard treatment regimen (three...

Isoniazid Hepatotoxicity Not Increased In Hepatitis C Patients.
November 19, 2001... 2001 NOV 19 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Liver damage associated with the tuberculosis drug isoniazid is not exacerbated in patients who are also infected with hepatitis or HIV, researchers say. ...